Medicinova Inc Share Price

Medicinova Inc Share Price

NASDAQ: MNOV | Micro Cap
$1.40
-$0.06 (-3.78%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Medicinova Inc Stock Performance

Open
$1.49
Prev. Close
$1.46
Circuit Range
N/A
Day Range
$1.40 - $1.49
Year Range
$1.20 - $3.89
Volume
951
Average Traded
$1.47

Medicinova Inc Share Price Today

As of 30 October 2026, Medicinova Inc's share price is $1.40. The stock opened at $1.49, compared to its previous close of $1.46. During today's trading session, Medicinova Inc's share price traded between $1.40 and $1.49, with an average price of $1.44. Over the past 52 weeks, the stock has recorded a high of $3.89 and a low of $1.20. In terms of performance, Medicinova Inc's share price has declined by 3.45% over the last six months and is down 16.17% on a year-on-year basis.

Medicinova Inc Share Price Chart

Line chart of the Medicinova Inc price trend over the selected period. The price fell overall, ranging from 1.39 to 1.49, ending at 1.40.
$1.40$1.49
L
Show Current Price
H

Medicinova Inc Stock Fundamentals & Key Indicators

Market Cap
$68.69M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.22
Revenue (TTM)
$410.00M
Return On Equity (TTM)
-28.85%
Profit Margin
-2926.83%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
24.26%

Medicinova Inc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.12$0.15$0.19$0.46
Net Profit-$3.05-$2.80-$2.59-$2.31
Net Profit Margin-2541.67%-1866.67%-1363.16%-502.17%
Income ChangeN/A8.20%7.50%10.81%

Medicinova Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$1.00$0.00$0.41
Net Profit-$14.07-$8.57-$11.05-$12.00
Net Profit MarginN/A-857.00%N/A-2926.83%
Income ChangeN/A39.09%-28.94%-8.60%

About Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Medicinova Inc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.66
$1.40
-17.16%
Sep 2026
$1.53
$1.69
+12.67%
Aug 2026
$1.32
$1.50
+12.78%
Jul 2026
$1.38
$1.33
+0.76%
Jun 2026
$1.34
$1.32
-3.30%
May 2026
$1.41
$1.36
-5.86%
Apr 2026
$1.40
$1.45
+5.84%
Mar 2026
$1.41
$1.37
-6.80%
Feb 2026
$1.67
$1.47
-15.52%
Jan 2026
$1.40
$1.74
+33.85%
Dec 2025
$1.47
$1.30
-10.96%
Nov 2025
$1.62
$1.46
-12.57%

MNOV Share Price FAQs